how do glp-1 agonists work for diabetes Frontiers GLP-1 Agonist-based Therapies: An Emerging
Description
Weekly injections have a longer window
Second, as a sensitivity analysis to address concerns regarding treatment indication heterogeneity, we repeated the primary analysis in a restricted cohort consisting of patients with T2D only
Liu T et al
Called liraglutide, the company began clinical testing of the drug for diabetes in 1997
The detailed background of the (patho)physiology of the incretin system and the history of the development of incretin-based glucose-lowering medications have recently been reviewed [15,16]
Continue reintroducing foods one at a time
